Novartis AG

OTC: NVSEF · Real-Time Price · USD
120.78
5.28 (4.57%)
At close: Aug 15, 2025, 1:24 PM
115.50
-4.37%
After-hours: Aug 13, 2025, 08:00 PM EDT

Novartis Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
11.94B 9.15B 6.96B 24.02B
Depreciation & Amortization
6.07B 8.28B 7.18B 6.11B
Stock-Based Compensation
1.04B 865M 791M 700M
Other Working Capital
555M 1.2B 464M 570M
Other Non-Cash Items
-2.43B -4.01B -1.14B -18.16B
Deferred Income Tax
1.7B 551M 1.42B 2.12B
Change in Working Capital
-706M -369M -1B 241M
Operating Cash Flow
17.62B 14.46B 14.24B 15.07B
Capital Expenditures
-3.81B -2.75B -2.67B -2.97B
Cash Acquisitions
-3.92B -3.54B -903M 20.1B
Purchase of Investments
-3.55B -747M -34.82B -16.59B
Sales Maturities Of Investments
3.7B 11.6B 39.49B 2.74B
Other Investing Acitivies
-2.38B 1.23B 368M 931M
Investing Cash Flow
-7.51B 5.6B 1.47B 4.21B
Debt Repayment
4.39B -1.79B -2.4B -2.44B
Common Stock Repurchased
-8.33B -8.72B -10.65B -3.06B
Dividend Paid
-7.62B -7.25B -7.75B -7.38B
Other Financial Acitivies
-177M 3.49B -4.79M -3.4B
Financial Cash Flow
-11.74B -14.28B -20.56B -16.26B
Net Cash Flow
-1.93B 5.88B -4.89B 2.75B
Free Cash Flow
13.8B 11.71B 11.56B 12.1B